Reaktion #73378
ord-73a39c32266f4d999a002c6507e44e38
Reaktionsgleichung
Edukte
Reagenzien
Reaktionsbedingungen
Aufarbeitung
- 1EinengenThe reaction is concentrated
- 2workup.ADDITIONdiluted with DCM (10 mL)
- 3Temperaturcooled to 0° C
- 4workup.ADDITIONTFA (5 mL) is then added
- 5Sonstigethe ice bath is removed
- 6workup.STIRRINGthe reaction is stirred at room temperature
- 7EinengenThe reaction is concentrated
- 8workup.ADDITIONdiluted with ethyl acetate
- 9workup.ADDITIONThe solution is then treated with 1N HCl
- 10SonstigeThe ethyl acetate is removed
- 11Sonstigedried
- 12Einengenconcentrated to a residue
- 13workup.DISSOLUTIONThe residue is dissolved in DMSO
- 14Sonstigepurified via HPLC (C18
Vorschrift
5-(6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yloxy)-N-(3-(trifluoromethyl)phenyl)-1H-indole-1-carboxamide (121.9 mg, 0.277 mmol) is dissolved in DMF (5 mL) and TEA (200 μl, 1.435 mmol) is added followed by t-butyl bromoacetate (101 μl, 0.693 mmol). The solution is stirred at rt overnight. The reaction is concentrated and then diluted with DCM (10 mL) and cooled to 0° C. TFA (5 mL) is then added and the ice bath is removed and the reaction is stirred at room temperature. The reaction is concentrated, basified with ammonium hydroxide, and diluted with ethyl acetate. The solution is then treated with 1N HCl. The ethyl acetate is removed, dried and concentrated to a residue. The residue is dissolved in DMSO and purified via HPLC (C18; 20-100% I/H2O with 0.1% TFA to obtain {4-[1-(3-Trifluoromethyl-phenylcarbamoyl)-1H-indol-5-yloxy]-5,7-dihydro-pyrrolo[3,4-d]pyrimidin-6-yl}-acetic acid. MS (ESI) m/z 498.9 (M+1); 1H NMR (400 MHz, MeOD) δ ppm 8.50 (s, 1 H)8.32 (d, J=8.84 Hz, 1 H)8.06 (s, 1 H)7.88-7.95 (m, 2 H)7.57 (t, J=7.96 Hz, 1 H)7.40-7.45 (m, 2 H)7.12 (dd, J=9.09, 2.02 Hz, 1 H)6.74 (d, J=3.79 Hz, 1 H)4.19 (d, J=9.35 Hz, 4 H), 3.43 (s, 2H).